Study on the clinical effect evaluation of Chinese patent medicine combined regimen for adenomyosis
- Conditions
- Adenomyosis
- Registration Number
- ITMCTR2000002910
- Lead Sponsor
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
(1) meet the clinical diagnostic criteria of adenomyosis;
(2) meet the diagnosis criteria of TCM syndromes;
(3) aged >= 25 and <= 50;
(4) patients who have not used any drugs with serious effects on liver and kidney function within 3 months;
(5) those who voluntarily participate in the study and sign the informed consent.
(1) primary dysmenorrhea, genital cancer or other local or systemic malignant tumors;
(2) patients with serious diseases of cardiovascular, cerebrovascular, liver, kidney or hematopoietic system;
(3) the introduction period of the case was not suitable for the author, or the case was combined with mental or neurological diseases and could not be cooperated;
(4) women who are pregnant or planning to be pregnant recently.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Menstrual volume rating table;visual analogue scale (VAS);
- Secondary Outcome Measures
Name Time Method Transvaginal gynecological ultrasound;TCM syndrome score table;Serum CA125;
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.